CC-BY 4.0 · TH Open 2017; 01(02): e139-e145
DOI: 10.1055/s-0037-1613679
DOI: 10.1055/s-0037-1613679
Original Article
Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial
Vinai C. Bhagirath
1
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
2
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
,
John W. Eikelboom
1
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
2
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
,
Jack Hirsh
1
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
2
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
,
Michiel Coppens
2
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
3
Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands
,
Jeffrey Ginsberg
1
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
,
Thomas Vanassche
2
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
4
Department of Cardiovascular Sciences, University Hospital, Leuven, Belgium
,
Fei Yuan
2
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
,
Noel Chan
1
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
2
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
,
Salim Yusuf
1
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
2
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
,
Stuart J. Connolly
1
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
2
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
› Institutsangaben
